The global Cell Culture Market is estimated to Growth Accelerated by Adoption of Single-Use Bioreactors

 

Cell culture is a process where living cells are grown under controlled sterile laboratory conditions. Cell culture techniques enable production of therapeutic proteins, vaccines, monoclonal antibodies and diagnostic tests. Rising prevalence of chronic diseases and growing demand for protein based drugs is driving need for increased cell culture capacity. Additionally single-use bioreactors that eliminate challenges associated with clean-in-place and sterilize-in-place processes are gaining rapid adoption in cell culture production, as they offer increased flexibility and are less capital intensive as compared to stainless-steel bioreactors.

The global Cell Culture Market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The growing adoption of single-use bioreactors is a key trend in the cell culture market. Single-use bioreactors are pre-sterilized and disposable bioreactors used for cell culture production. They eliminate the need for validating cleaning and sterilization processes required for reusable stainless steel bioreactors. Additionally, single use bioreactors offer improved flexibility as production can be stopped and restarted easily without the need for cleaning validations. Their easy implementation and disposable nature significantly reduces operational costs for cell culture manufacturers. As a result, single-use bioreactors are rapidly gaining preference over conventional reusable bioreactors, thereby driving growth of the overall cell culture market during the forecast period.


Segment Analysis

The global cell culture market is divided into sub-segments based on product, application, end-user and geography. Based on product, the market is segmented into media, sera, reagents, and bioreactors/incubators. Among these, the media segment currently dominates the market due to high demand for media and growth factors as they form the base for cell cultures. The sera segment also has a significant share due to widespread adoption of fetal bovine serum for cell-line development and cell culturing processes.

Key Takeaways

The global cell culture market is expected to witness high growth during the forecast period of 2023 to 2030. The global Cell Culture Market is estimated to be valued at US$ 19,198.0 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030.


Regional analysis related content comprises:
North America holds the largest share in the cell culture market mainly due to extensive medical research and technological advancements in the region. The presence of major players along with high healthcare expenditure and funding for medical research further boost the market growth in North America. However, Asia Pacific is projected to experience the highest growth during the forecast period. This can be attributed to increasing prevalence of various chronic diseases, improving healthcare infrastructure, and growing government support for life science research in developing countries such as China and India.

Key players related content comprises:
Key players operating in the cell culture market include Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. Among these, Thermo Fisher Scientific Inc. and Merck KGaA hold a significant market share owing to their broad product portfolio and strong global presence.

Comments

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure